A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER

被引:0
|
作者
Ikeda, Takaya [1 ]
Taniguchi, Hirokazu [1 ]
Soda, Hiroshi [1 ]
Fukuda, Minoru [2 ]
Kinoshita, Akihito [3 ]
Fukuda, Masaaki [4 ]
Soejima, Yoshifumi [5 ]
Ogawara, Daiki [6 ]
Nakamura, Yoichi [6 ]
Kohno, Shigeru [6 ]
机构
[1] Sasebo City Gen Hosp, Hirase, Sasebo, Japan
[2] Japanese Red Cross Nagasaki, Isahaya, Nagasaki, Japan
[3] Nagasaki Prefecture Shimabara Hosp, Shimabara, Nagasaki, Japan
[4] Natl Hosp, Org Nagasaki Med Ctr, Omura, Nagasaki, Japan
[5] Ureshino Med Ctr, Ureshina, Japan
[6] Nagasaki Univ Hosp, Dept Internal Med 2, Nagasaki, Japan
关键词
Extensive-Disease Small Cell Lung Cancer; amrubicin; chemotherapy; Carboplatin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.10-005
引用
收藏
页码:S1157 / S1157
页数:1
相关论文
共 50 条
  • [41] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
    Minoru Fukuda
    Mikio Oka
    Hiroshi Soda
    Akitoshi Kinoshita
    Masaaki Fukuda
    Seiji Nagashima
    Mutsuo Kuba
    Hiroshi Takatani
    Junji Tsurutani
    Yoichi Nakamura
    Takashi Kasai
    Yuichi Inoue
    Yoshifumi Soejima
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 573 - 577
  • [42] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Andre Michel Kallab
    Yasolatha Nalamolu
    Paul Maclyn Dainer
    Anand Prasad Jillella
    Medical Oncology, 2005, 22 : 145 - 151
  • [43] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Kallab, AM
    Nalamolu, Y
    Dainer, PM
    Jillella, AP
    MEDICAL ONCOLOGY, 2005, 22 (02) : 145 - 151
  • [44] Phase I study of amrubicin and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
    Sorensen, Morten
    Lassen, Ulrik
    Jensen, Peter Buhl
    Osterlind, Kell
    Jeppesen, Nina
    Jensen, Britta Bjerregaard
    Mellemgaard, Anders
    Rytter, Carsten
    Langer, Seppo Wang
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 902 - 906
  • [46] A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancer
    Kim, S. J.
    Kim, J. S.
    Kim, S. C.
    Kim, Y. K.
    Kim, Y. K.
    Kang, J. Y.
    Yoon, H. K.
    Song, J. S.
    Lee, S. H.
    Moon, H. S.
    Kim, J. W.
    Kim, K. H.
    Kim, C. H.
    Shim, B. Y.
    Kim, H. K.
    LUNG CANCER, 2010, 68 (03) : 446 - 449
  • [47] Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer
    Reck, Martin
    Horn, Leora
    Novello, Silvia
    Barlesi, Fabrice
    Albert, Istvan
    Juhasz, Erzsebet
    Kowalski, Dariusz
    Robinet, Gilles
    Cadranel, Jacques
    Bidoli, Paolo
    Chung, John
    Fritsch, Arno
    Drews, Uta
    Wagner, Andrea
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : 701 - 711
  • [48] Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer
    Igawa, Satoshi
    Otani, Sakiko
    Ryuge, Shinichiro
    Fukui, Tomoya
    Nakahara, Yoshiro
    Hiyoshi, Yasuhiro
    Ishihara, Mikiko
    Kusuhara, Seiichiro
    Harada, Shinya
    Mitsufuji, Hisashi
    Kubota, Masaru
    Sasaki, Jiichiro
    Masuda, Noriyuki
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 642 - 648
  • [49] A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese Patients
    Tamiya, Motohiro
    Iwasawa, Shunichiro
    Sasaki, Yusuke
    Tajima, Kosei
    Chiba, Yasutaka
    ADVANCES IN THERAPY, 2024, 41 (09) : 3539 - 3556
  • [50] Phase II trial of pemetrexed (P) and carboplatin (C) in previously untreated extensive stage disease small cell lung cancer (ED-SCLC): A NCCTG Study
    Jett, J. R.
    Bernath, A. M.
    Foster, N. R.
    Molina, J. R.
    Nikcevich, D. A.
    Steen, P. D.
    Flynn, P. J.
    Rowland, K. M., Jr.
    Fitch, T. R.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)